凯胺作为主要抑郁症辅助治疗的研究方案 (2):随机对照试验 (KARMA-Dep [2])
Ana Jelovac1, Cathal McCaffrey1, Masashi Terao1
1Department of Psychiatry, Trinity College Dublin, St. Patrick's University Hospital, James Street, Dublin, D08 K7YW, Ireland.
BMC psychiatry
|November 17, 2023
概括
这项试验调查了针对重大抑郁症发作的连续胺注射与米达佐拉姆. 它评估了疗效,安全性和成本效益,以告知新型抗抑郁药治疗的临床实践.
科学领域:
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
- 卫生经济学 卫生经济学
背景情况:
- 抑郁症是全球导致残疾的主要原因,常规抗抑郁药有效性有限.
- 目前的治疗方法,如单氨基抗抑郁药,起作用缓慢,有效性有限.
- 虽然胺显示出快速的抗抑郁作用,但它们是短暂的,因此需要对长期使用的方法进行研究.
研究的目的:
- 为了评估连续胺注射的疗效和安全性,与主要抑郁症发作中的活性比较剂 (midazolam) 相比.
- 提供有关反应,缓解和复发率的数据.
- 评估重复注入胺的安全性,耐受性,生活质量和成本效益.
主要方法:
- 一个实用,随机,受控,患者和评分者盲目的优越性试验,涉及患有重大抑郁症的成年住院患者.
- 参与者每周两次,每周两次,每周两次,每周两次,每周两次,每周两次,每周两次,每周两次,每周两次,每周两次.
- 主要结局是蒙哥马利-阿斯伯格抑郁评分表得分的差异,从基线到最终输注后24小时;24周的随访监测复发.
主要成果:
- 试验正在进行中,结果尚未公布.
- 通过比较胺和米达佐拉姆组之间的抑郁症评分表得分来确定有效性.
- 安全性和耐受性将通过监测心理模拟,认知和身体副作用来评估.
结论:
- 这项研究旨在解决快速起作用抗抑郁药的未满足的临床需求.
- 这些发现将为临床实践提供关于连续胺注射在治疗抑郁症中的作用的信息.
- 该试验将提供关键的疗效,安全和健康经济数据.
更多相关视频
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
31.4K
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
01:30Electroconvulsive Therapy
44
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
44
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180